Reviva Pharmaceuticals to Host Key Opinion Leader Event on Brilaroxazine (RP5063) in Phase 3 Clinical Trials for Schizophrenia
Virtual event on Tuesday, May 2, 2023 at 11:00am ET will feature key opinion leader…
News
Invivyd Announces the FDA Has Cleared Its IND Application for VYD222, a Monoclonal Antibody Candidate for Prevention of COVID-19, and Provides Phase 1 VYD222 Clinical Trial Update
On track for initial readouts in Q2 2023 from ongoing Phase 1 VYD222 clinical trial…
Invivyd Announces the FDA Has Cleared Its IND Application for VYD222, a Monoclonal Antibody Candidate for Prevention of COVID-19, and Provides Phase 1 VYD222 Clinical Trial Update
On track for initial readouts in Q2 2023 from ongoing Phase 1 VYD222 clinical trial…
Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures
-MORF-057 demonstrates statistically significant reduction of 6.4 points (p=0.002) from baseline at Week 12 in…
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
SOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures
-MORF-057 demonstrates statistically significant reduction of 6.4 points (p=0.002) from baseline at Week 12 in…
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
-In EMERALD-1 Phase 2a trial in patients with ulcerative colitis, MORF-057 meets primary endpoint and…
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
SOUTH SAN FRANCISCO, Calif., April 25, 2023 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS…
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
-In EMERALD-1 Phase 2a trial in patients with ulcerative colitis, MORF-057 meets primary endpoint and…
HilleVax Announces Completion of Enrollment of NEST-IN1 Phase 2b Clinical Study of HIL-214 Norovirus Vaccine Candidate
Topline safety and clinical efficacy data from NEST-IN1 expected in the first quarter of 2024…
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS…
Megaputer to present capabilities and benefits of Insight-D™ NLP solution for insight discovery in pharmaceutical data
BLOOMINGTON, Ind., April 25, 2023 (GLOBE NEWSWIRE) — Megaputer will reveal its new Insight-D™ insight…
Megaputer to present capabilities and benefits of Insight-D™ NLP solution for insight discovery in pharmaceutical data
BLOOMINGTON, Ind., April 25, 2023 (GLOBE NEWSWIRE) — Megaputer will reveal its new Insight-D™ insight…
ibex to Showcase Next-Generation CX Solutions for Utilities at CS Week 2023
ibex Empowers Utilities to Establish and Maintain Meaningful Connections with Customers Across the Entire Utility…
ibex to Showcase Next-Generation CX Solutions for Utilities at CS Week 2023
ibex Empowers Utilities to Establish and Maintain Meaningful Connections with Customers Across the Entire Utility…
Tenable One to Support On-Premises and Hybrid Deployments With Integration of Tenable Security Center
Increased deployment flexibility makes exposure management more accessible for customers COLUMBIA, Md., April 25, 2023…
Tenable One to Support On-Premises and Hybrid Deployments With Integration of Tenable Security Center
Increased deployment flexibility makes exposure management more accessible for customers COLUMBIA, Md., April 25, 2023…
ProvisionAI Receives Patent for Managing Optimization of a Network Flow
Patent Technology Covers the Optimization of Deployment Transportation Network Based on Constraints and Prioritizes Product…
ProvisionAI Receives Patent for Managing Optimization of a Network Flow
Patent Technology Covers the Optimization of Deployment Transportation Network Based on Constraints and Prioritizes Product…